Glucagon-like peptide 1 (University of Virginia)

胰高血糖素样肽(弗吉尼亚大学)

Report date: 2022/04/01 13:18:22

Base Information

Drug NameGlucagon-like peptide 1 (University of Virginia)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsInsulin ResistanceDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Virginia
Active IndicationsN/A
Inactive IndicationsInsulin ResistanceDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A